THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Considering, The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended On 30Th June, 2020 On Friday, 14Th August, 2020
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2020 ,inter alia, to consider and approve to consider, the Un-audited Standalone and Consolidated Financial Results for the Quarter ended on 30th June, 2020. THEMIS MEDICARE LTD. - 530199 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) read with SEBI Circular CIR/CFD/ CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company issued by M/s. Shirish Shetye & Associates, Company Secretaries for the financial year 2019 -20. This is for the information of the exchange and the members THEMIS MEDICARE LTD. - 530199 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Impact Of COVID-19
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby submit disclosure of impact of COVID-19 Pandemic on the operations and on business of the Company. The Detailed impact of COVID-19 Pandemic in terms of SEBI circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 is enclosed below. This is for your information and record. THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record. THEMIS MEDICARE LTD. - 530199 - Shareholding for the Period Ended June 30, 2020
Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer THEMIS MEDICARE LTD. - 530199 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2020. This is for your information and record. THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 02.04.19 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 01.07.20 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30.06.20 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter ended 30.06.20 shall be intimated in due course. We request you to kindly take the above information on record. THEMIS MEDICARE LTD. - 530199 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayTHEMIS MEDICARE LTD. 2CINL24110GJ1969PLC001590 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 7.08 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sangameshwar Iyer Designation: Company Secretary and Compliance Ofiicer EmailId: sangameshwar.iyer@themismedicare.com Name of the Chief Financial Officer: Tushar J Dalal Designation: Chief Financial Officer EmailId: tushar.dalal@themismedicare.com Date: 23/06/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.